SNCA and Parkinson disease: The central role of alpha-synuclein pathology is well-described in Parkinson’s disease.5-10 There is also evidence for an immune response to alpha-synuclein with the identification of T cells specific to alpha-synuclein in Parkinson’s disease patients6 as well as alpha-synuclein–specific antibodies (reviewed in Scott et al. 7).